Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2338 of 6351
-
New scan could spot rare tumors better than current gold standard
Diagnosis Recruiting nowThe aim of this study is to evaluate the diagnostic performance of Al18F-NOTA-LM3 PET/CT and compare it with 68Ga-DOTATATE PET/CT in patients with pheochromocytoma/paraganglioma (PPGL).
Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
Gene-Tailored drug dosing aims to protect young transplant patients
Disease control Recruiting nowThis study aims to evaluate the efficacy of genotype-informed Bayesian dosing of tacrolimus in optimising drug exposure among paediatric solid organ transplant recipients. By tailoring tacrolimus dosage based on individual genetic makeup and using Bayesian modeling to predict dru…
Phase 4 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New Preservative-Free eye drops take on glaucoma in Head-to-Head trial
Disease control CompletedThe main purpose is to compare the ocular hypotensive efficacy and safety of two concentrations of T4090 (Kinezodianone R HCl 0.2% and 0.3%) ophthalmic solution with Rhopressa® ophthalmic solution
Phase 2 • Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Poop pills? fecal transplants tested for liver disease
Disease control CompletedThe study aims to investigate the beneficial effects of fecal transplantation in patients diagnosed with liver cirrhosis (regardless of etiology).
Phase 3 • Sponsor: Cristian Ichim • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Anesthesia choice may influence lung cancer return, major trial investigates
Knowledge-focused Recruiting nowThere has been ongoing debate about the relationship between cancer recurrence and anesthetic management. Therefore, the investigators will test the hypothesis that the recurrence free survival (RFS) after curative resection of NSCLC is higher in patient who received total intrav…
Phase 4 • Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Could a Once-Daily pill replace needles for kids with blood clots?
Disease control CompletedProspective interventional randomized controlled trial to assess safety and efficacy of rivaroxaban in pediatric patients with acute deep venous thrombosis.
Phase 4 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a common mineral ease rare genetic disorder? zinc trial shows promise
Disease control CompletedThe goal of this clinical trial is to investigate feasibility and safety of an oral therapy with zinc in patients affected by Guanine nucleotide-binding protein G(o) subunit alpha (GNAO1) associated disorders. The main questions it aims to answer are: * Is a daily oral therapy …
Phase 2 • Sponsor: Children's University Hospital Cologne, Germany • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New obesity drug KN069 enters first human tests
Disease control Recruiting nowThis is a Phase 1, First-in-human, double-blinded, placebo-controlled study which aims to investigate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and the immunogenicity of KN069 in Chinese male participants with Obesity or Overweight.
Phase 1 • Sponsor: Suzhou Alphamab Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 18:13 UTC
-
Can faster brain zaps beat teen depression?
Symptom relief Recruiting nowRepetitive transcranial magnetic stimulation (rTMS) is a Health Canada approved treatment for major depression. Theta burst stimulation (TBS), a type of rTMS, is a very promising new treatment for major depression in adults and adolescents. However, very few studies have assessed…
Sponsor: The Royal Ottawa Mental Health Centre • Aim: Symptom relief
Last updated Jun 26, 2026 14:34 UTC
-
Antioxidant supplement may ease chemo toxicity in breast cancer
Symptom relief Completedinvestigating the potential effect of Coenzyme Q10 in ameliorating and preventing the development of paclitaxel chemotherapeutic toxicity in breast cancer patients
Phase 2 • Sponsor: Damanhour University • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Can a simple blood test spot cancer early? 25,000 volunteers help find out
Diagnosis Recruiting nowThis is a multi-site registry of patients receiving the Exact Sciences Multicancer Early Detection (MCED) test.
Sponsor: Exact Sciences Corporation • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
Scientists hunt for tinnitus fingerprint in the brain
Diagnosis CompletedResearch in clinical neuroscience is founded on the conviction that a better understanding of tinnitus related changes of brain function will improve our ability to diagnose and treat tinnitus. Although considerable advances have been made in understanding the mechanisms of tinni…
Sponsor: University of Regensburg • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
Safer pain block could cut opioid use in lung surgery
Symptom relief Recruiting nowThoracotomy is among the most painful surgical procedures and can cause severe pain with a high incidence. Inadequate treatment of acute postoperative pain may lead to undesired complications. Paravertebral block (PVB) is an effective technique that provides adequate analgesia in…
Sponsor: Kocaeli University • Aim: Symptom relief
Last updated Jun 26, 2026 14:03 UTC
-
New drug shows promise for slowing kidney disease in alport syndrome
Disease control CompletedThis study is a proof-of-concept trial of vonafexor safety, its effects on kidney function in subjects with at risk of progression Alport syndrome.
Phase 2 • Sponsor: Enyo Pharma • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Can a simple video boost wrist surgery recovery?
Symptom relief Recruiting nowThis study is a randomized controlled trial (RCT). This RCT which will study the effect of performing daily activities early after a distal radius fracture being treated with surgical intervention of open reduction and internal fixation. This study will have two groups. The exper…
Phase 1 • Sponsor: George Washington University • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Gut microbiome may hold key to personalized Crohn's therapy
Knowledge-focused Recruiting nowThe goal of this prospective observational study is to determine if specific microbiome signatures can predict therapeutic responses in adult patients with Crohn's disease (CD), a form of inflammatory bowel disease (IBD), living in British Columbia, Canada. The main questions thi…
Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Anchor fixation may stop bowel twists without major surgery
Disease control CompletedThe investigators included all patients who were presented to emergency department with recurrent sigmoid volvulus at Zagazig University hospital between (August 2024 to August 2025). The investigators included patients were of the American Society of Anesthesiologists (ASA) Phys…
Sponsor: Zagazig University • Aim: Disease control
Last updated Jun 26, 2026 14:04 UTC
-
Simple toothbrushing may cut ventilator pneumonia risk
Prevention CompletedA Randomized Controlled Trial (RCT) at Services Hospital, Lahore, aims to reduce Ventilator-Associated Pneumonia (VAP) incidence and mortality rates while shortening ICU stays in mechanically ventilated patients by adding adjuvant oral care to traditional practices. Study Object…
Sponsor: University of Health Sciences Lahore • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Head-to-Head: which seizure drug works best for kids?
Disease control CompletedDespite increasing clinical use of both agents, there is a paucity of head-to-head comparative data on the safety and efficacy of brivaracetam versus levetiracetam as initial monotherapy in children. The present study was therefore designed to compare the safety and efficacy of o…
Sponsor: RESnTEC, Institute of Research • Aim: Disease control
Last updated Jun 26, 2026 15:06 UTC
-
New hope for kids with rare swelling disorder: sebetralstat shows promise
Symptom relief CompletedKVD900-303 is an open-label, multicenter clinical trial in patients aged 2 to 11 years old with HAE Type I or II.
Phase 3 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC